Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.33 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | FKBP1A | P62942 | 2/20 | 0.32 |
| ▸ | FKBP4 | Q02790 | 1/20 | 0.32 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.32 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.32 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8790645 | 0.88 | BRD4 (0.36) | HRH3SMN1; SMN2 | |
| SCHEMBL7356483 | 0.81 | ALDH1A1 (0.36) | HRH3PARP14ALDH1A1FKBP1AFKBP4 | |
| SCHEMBL22117724 | 0.72 | ALDH1A1 (0.35) | HRH3PARP14ALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL22117720 | 0.72 | ALDH1A1 (0.35) | HRH3PARP14ALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL28640464 | 0.72 | ALDH1A1 (0.35) | HRH3PARP14ALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL2607204 | 0.69 | NCF1 (0.41) | PARP14ALDH1A1ITGB3ITGA2BPOLB | |
| SCHEMBL11079358 | 0.69 | TSHR (0.37) | HRH3ALDH1A1ITGB3ITGA2BPOLB | |
| SCHEMBL28653258 | 0.69 | ALDH1A1 (0.36) | HRH3ALDH1A1KDM4ESMN1; SMN2GAA | |
| SCHEMBL2603283 | 0.68 | POLB (0.38) | HRH3PARP14ITGB3ITGA2BPOLB | |
| SCHEMBL7359364 | 0.68 | BRD4 (0.46) | HRH3SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0800516-A1 | FIBRINOGEN RECEPTOR ANTAGONISTS HAVING SUBSTITUTED (b)-AMINO ACID RESIDUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | NIPPON STEEL CORPORATION (JP) | 1997-10-15 | — | — | EP | disclosed |